Trial Profile
Pharmacokinetics and Safety of Human Pasteurised C1-Inhibitor Concentrate (Berinert/CE1145) in Subjects with Congenital C1-INH Deficiency and Frequent Hereditary Angioedema (HAE) Attacks. Studio della farmacocinetica e della sicurezza del C1-Inibitore concentrato pasteurizzato umano (Berinert/CE1145) in soggetti con deficienza congenita di C1-INH e frequenti attacchi di angioedema ereditario (HAE).
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Mar 2014
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Hereditary angioedema
- Focus Pharmacokinetics
- Sponsors CSL Behring
- 09 Mar 2014 New trial record